• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于RNA的循环肿瘤细胞分析为转移性乳腺癌提供预后信息。

RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer.

作者信息

Strati Areti, Nikolaou Michail, Georgoulias Vassilis, Lianidou Evi S

机构信息

Analysis of Circulating Tumor Cells Lab, Department of Chemistry, University of Athens, 15771 Athens, Greece.

Medical Oncology Unit, "Elena Venizelou" Hospital, 11521 Athens, Greece.

出版信息

Diagnostics (Basel). 2021 Mar 14;11(3):513. doi: 10.3390/diagnostics11030513.

DOI:10.3390/diagnostics11030513
PMID:33799422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7998407/
Abstract

In metastatic breast cancer (MBC) the molecular characterization of circulating tumor cells (CTCs) provides a unique tool to understand metastasis-biology and therapy-resistance. We evaluated the prognostic significance of gene expression in EpCAM CTCs in 46 MBC patients based on a long follow-up. We selected a panel consisting of stem cell markers (, , ), the mesenchymal marker , receptors (, , , ) and the epithelial marker . Singleplex RT-qPCR was used for and and multiplex RT-qPCR for stem cell markers and receptors. A group of 19 healthy donors (HD) was used as control. Univariate ( = 0.001) and multivariate analysis ( = 0.002) revealed the prognostic value of combined gene expression of (+), , and over-expression for overall survival (OS). The Kaplan-Meier estimates of OS were significantly different in patients positive for ( = 0.028), ( = 0.002), ( = 0.007) and -positive ( = 0.022). Our results indicate that combined gene expression analysis in EpCAM CTCs provides prognostic information in MBC.

摘要

在转移性乳腺癌(MBC)中,循环肿瘤细胞(CTC)的分子特征为理解转移生物学和治疗耐药性提供了一个独特的工具。基于长期随访,我们评估了46例MBC患者中EpCAM CTCs基因表达的预后意义。我们选择了一个由干细胞标志物(……)、间充质标志物、受体(……)和上皮标志物组成的基因组合。对……使用单重RT-qPCR,对干细胞标志物和受体使用多重RT-qPCR。一组19名健康供体(HD)用作对照。单因素分析(……)和多因素分析(……)显示,(+)、……、……和……过表达的联合基因表达对总生存期(OS)具有预后价值。在……阳性(……)、……阳性(……)、……阳性(……)和……阳性(……)的患者中,OS的Kaplan-Meier估计值有显著差异。我们的结果表明,EpCAM CTCs中的联合基因表达分析可为MBC提供预后信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/0979f2c3f10f/diagnostics-11-00513-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/b2ed6717ce02/diagnostics-11-00513-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/c2e1e47911af/diagnostics-11-00513-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/436f25752764/diagnostics-11-00513-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/0979f2c3f10f/diagnostics-11-00513-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/b2ed6717ce02/diagnostics-11-00513-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/c2e1e47911af/diagnostics-11-00513-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/436f25752764/diagnostics-11-00513-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165d/7998407/0979f2c3f10f/diagnostics-11-00513-g004.jpg

相似文献

1
RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer.基于RNA的循环肿瘤细胞分析为转移性乳腺癌提供预后信息。
Diagnostics (Basel). 2021 Mar 14;11(3):513. doi: 10.3390/diagnostics11030513.
2
Prognostic Significance of , , , and Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients.早期乳腺癌患者 EpCAM 阳性循环肿瘤细胞中 、 、 、 和 转录本定量的预后意义。
Cells. 2019 Jun 29;8(7):652. doi: 10.3390/cells8070652.
3
Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer.全面的液体活检分析作为乳腺癌微小残留病灶早期检测的工具。
Sci Rep. 2023 Jan 23;13(1):1258. doi: 10.1038/s41598-022-25400-1.
4
A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer.在乳腺癌中对体内分离的 EpCAM 阳性循环肿瘤细胞进行全面的分子分析。
Clin Chem. 2021 Oct 1;67(10):1395-1405. doi: 10.1093/clinchem/hvab099.
5
Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer.循环肿瘤细胞及配对血浆来源外泌体中基因表达和DNA甲基化标志物在转移性去势抵抗性前列腺癌中的预后意义
Cancers (Basel). 2021 Feb 13;13(4):780. doi: 10.3390/cancers13040780.
6
Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.将 microRNA 纳入循环肿瘤细胞的分子表型可提高转移性乳腺癌患者的预后准确性。
Oncologist. 2019 Nov;24(11):e1044-e1054. doi: 10.1634/theoncologist.2018-0697. Epub 2019 Jul 12.
7
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer.乳腺癌干细胞标志物的表达作为HER2阳性乳腺癌预后及对曲妥珠单抗反应的预测指标
Br J Cancer. 2016 May 10;114(10):1109-16. doi: 10.1038/bjc.2016.101. Epub 2016 Apr 26.
8
Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer.浸润性乳腺癌中类干细胞循环肿瘤细胞的异质性。
Int J Mol Sci. 2020 Apr 16;21(8):2780. doi: 10.3390/ijms21082780.
9
Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.卵巢癌中单个循环肿瘤细胞的基因表达谱分析——多标记基因panel的建立。 (注:这里“panel”可译为“组、面板等,结合语境可能是指一组相关基因,因未明确专业释义,保留英文更合适)
Mol Oncol. 2016 Aug;10(7):1030-42. doi: 10.1016/j.molonc.2016.04.002. Epub 2016 Apr 20.
10
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.建立一个多标志物定量聚合酶链反应(qPCR)检测板,用于对转移性乳腺癌患者姑息治疗过程中血样中的循环肿瘤细胞进行分子特征分析。
Oncotarget. 2016 Jul 5;7(27):41677-41690. doi: 10.18632/oncotarget.9528.

引用本文的文献

1
Microfluidic Biosensors: Enabling Advanced Disease Detection.微流控生物传感器:助力先进疾病检测
Sensors (Basel). 2025 Mar 20;25(6):1936. doi: 10.3390/s25061936.
2
Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine.循环肿瘤细胞:起源、作用、当前应用及个性化医疗的未来展望
Biomedicines. 2024 Sep 20;12(9):2137. doi: 10.3390/biomedicines12092137.
3
Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis.

本文引用的文献

1
Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients.纵向多参数液体活检方法可识别循环肿瘤细胞、细胞外囊泡和无细胞 DNA 特征的独特性,用于转移性乳腺癌患者的疾病监测。
Cells. 2021 Jan 21;10(2):212. doi: 10.3390/cells10020212.
2
Liquid biopsy enters the clinic - implementation issues and future challenges.液体活检进入临床——实施问题与未来挑战。
Nat Rev Clin Oncol. 2021 May;18(5):297-312. doi: 10.1038/s41571-020-00457-x. Epub 2021 Jan 20.
3
Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients.
循环肿瘤细胞作为早期胰腺癌潜在的预后生物标志物:一项系统综述和荟萃分析。
World J Clin Oncol. 2023 Nov 24;14(11):504-517. doi: 10.5306/wjco.v14.i11.504.
4
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management.液体活检的多样性及其在乳腺癌管理中的潜力。
Cancers (Basel). 2023 Nov 17;15(22):5463. doi: 10.3390/cancers15225463.
5
Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting.循环肿瘤细胞的检测与分子特征分析:临床环境面临的挑战
Cancers (Basel). 2023 Apr 6;15(7):2185. doi: 10.3390/cancers15072185.
6
Data on 2D culture characterisation of potential markers in human HER2-positive breast cancer cell lines.关于人HER2阳性乳腺癌细胞系中潜在标志物的二维培养特征数据。
Data Brief. 2023 Jan 7;46:108880. doi: 10.1016/j.dib.2022.108880. eCollection 2023 Feb.
7
Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes.血液中乳腺癌进展的特征:从循环肿瘤细胞转录组中能学到什么。
Cancers (Basel). 2022 Nov 18;14(22):5668. doi: 10.3390/cancers14225668.
8
Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients.微流控平台在乳腺癌患者循环肿瘤细胞富集中的比较。
Breast Cancer Res Treat. 2022 Nov;196(1):75-85. doi: 10.1007/s10549-022-06717-x. Epub 2022 Sep 8.
9
Metabolism-Related Gene Expression in Circulating Tumor Cells from Patients with Early Stage Non-Small Cell Lung Cancer.早期非小细胞肺癌患者循环肿瘤细胞中与代谢相关的基因表达
Cancers (Basel). 2022 Jun 30;14(13):3237. doi: 10.3390/cancers14133237.
10
The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer.乳腺癌干细胞在三阴性乳腺癌化疗耐药和转移中的作用
Cancers (Basel). 2021 Dec 9;13(24):6209. doi: 10.3390/cancers13246209.
转移性去势抵抗性前列腺癌患者循环肿瘤细胞的全基因组表达特征分析
J Clin Med. 2020 Jul 1;9(7):2066. doi: 10.3390/jcm9072066.
4
Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.转移性乳腺癌中循环肿瘤细胞特征的研究进展:单细胞分析及其相互作用,以及用于药物测试的患者来源模型。
Adv Exp Med Biol. 2020;1220:61-80. doi: 10.1007/978-3-030-35805-1_5.
5
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.新型循环肿瘤 DNA 下一代测序平台与转移性乳腺癌中循环肿瘤细胞 (CTC) 和 CTC 簇的关联。
Breast Cancer Res. 2019 Dec 4;21(1):137. doi: 10.1186/s13058-019-1229-6.
6
Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients.在接受雌激素剥夺治疗的转移性 luminal 乳腺癌患者的单个循环肿瘤细胞中检测到 ESR1 突变,但在原发性肿瘤中未检测到。
J Mol Diagn. 2020 Jan;22(1):111-121. doi: 10.1016/j.jmoldx.2019.09.004. Epub 2019 Oct 24.
7
Prognostic Significance of , , , and Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients.早期乳腺癌患者 EpCAM 阳性循环肿瘤细胞中 、 、 、 和 转录本定量的预后意义。
Cells. 2019 Jun 29;8(7):652. doi: 10.3390/cells8070652.
8
The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling.通过序贯 CTC-异种移植建模鉴定三阴性乳腺癌肝转移基因特征。
Mol Oncol. 2019 Sep;13(9):1913-1926. doi: 10.1002/1878-0261.12533. Epub 2019 Jun 19.
9
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.循环肿瘤细胞 (CTC) 计数在转移性乳腺癌 (MBC) 分期中的临床应用:国际专家共识文件。
Crit Rev Oncol Hematol. 2019 Feb;134:39-45. doi: 10.1016/j.critrevonc.2018.12.004. Epub 2018 Dec 19.
10
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.转移性乳腺癌患者的临床结局与循环肿瘤细胞和循环游离 DNA 的关系。
Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4.